Concepedia

Author

Ian Hann

University College London

Also Known As

CR Pinkerton, I Hann, I M Hann, I. HANN, I. Hann, I. M Hann, I. M. HANN, I. M. Hann, I.M Hann, I.M. Hann

199

Publications

14.1K

Citations

56

H-Index

128

Concepts

All Affiliations

University College LondonGreat Ormond Street HospitalRoyal Manchester Children's HospitalRoyal Hospital for ChildrenSheffield Children's Hospital
IH

About

Ian Hann is an author at University College London specializing in medicine, hematology, and pediatrics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

47

4.7K

2

Health Sciences

13

13

1.7K

3

Public Health

4

4

249

4

Allergy

1

1

113

5

Biomedical Engineering

1

1

10

Ian Hann

×

106

Publications

13.1K

Citations

53

H-Index

YearCitations

The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

David Grimwade, Helen M. Walker, Fiona Oliver,

Blood

1998

2.6K

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

Rob Pieters, Martin Schrappe, Paola De Lorenzo,

The Lancet

2007

644

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

Alan K. Burnett, Anthony H. Goldstone, Richard MF Stevens,

The Lancet

1998

565

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

H. G. Prentice, Ian Hann, Raoul Herbrecht,

British Journal of Haematology

1997

438

A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

Keith Wheatley, Alan K. Burnett, Anthony H. Goldstone,

British Journal of Haematology

1999

434

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

Alan K. Burnett, Keith Wheatley, Anthony H. Goldstone,

British Journal of Haematology

2002

340

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial

Richard Stevens, Ian Hann, Keith Wheatley,

British Journal of Haematology

1998

308

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

Christine J. Harrison, Robert K. Hills, Anthony V. Moorman,

Journal of Clinical Oncology

2010

303

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

B Gibson, Keith Wheatley, Ian Hann,

Leukemia

2005

302

Randomized Comparison of DAT Versus ADE as Induction Chemotherapy in Children and Younger Adults With Acute Myeloid Leukemia. Results of the Medical Research Council's 10th AML Trial (MRC AML10)

Ian Hann, Richard Stevens, Anthony H. Goldstone,

Blood

1997

301

Page 1